Praxis Precision Medicines, Inc. (PRAX)
241.76
-6.48
(-2.61%)
USD |
NASDAQ |
Oct 16, 16:00
242.00
+0.24
(+0.10%)
After-Hours: 20:00
Praxis Precision Medicines Research and Development Expense (Annual) : 267.12M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 267.12M |
| December 31, 2024 | 152.41M |
| December 31, 2023 | 86.77M |
| December 31, 2022 | 155.04M |
| Date | Value |
|---|---|
| December 31, 2021 | 120.26M |
| December 31, 2020 | 44.98M |
| December 31, 2019 | 28.88M |
| December 31, 2018 | 18.82M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| BioMarin Pharmaceutical, Inc. | 700.97M |
| Insmed, Inc. | 771.09M |
| Vertex Pharmaceuticals, Inc. | 3.754B |
| Ironwood Pharmaceuticals, Inc. | 93.26M |
| Xencor, Inc. | 239.43M |